The DOI matches its Crossref record.
Autoantibodies Against Oxidized Low Density Lipoprotein in Patients With Angiographically Verified Coronary Artery Disease
Open accessAbstract
Abstract —Oxidation of low density lipoproteins (LDL) obviously plays an important role in the pathogenesis of atherosclerosis. The purpose of the study was to determine whether antibodies against oxidized LDL are associated with coronary artery disease (CAD). We determined the serum levels of antibodies against copper-oxidized LDL by enzyme-linked immunosorbent assay in 58 patients with angiographically verified CAD and 34 controls without CAD. The mean antibody level, expressed in optical density units, was significantly higher in patients than in controls (0.150±0.088 versus 0.094±0.054, respectively; P =0.00089). In logistic regression analysis, high antibody level against oxidized LDL was associated significantly with CAD ( P =0.0114), independent of age ( P =0.00137), gender ( P =0.0021), body mass index ( P =0.5947), triglyceride concentration ( P =0.9813), and total cholesterol–high density lipoprotein (HDL) cholesterol ( P =0.0080) group. Similar analysis in nondiabetic subjects (n=79) and in men only (n=75) showed analogous results, with only minor changes in P values. The antibody level against oxidized LDL differed significantly between nonsmokers and smokers in CAD patients ( P <0.00197) but not in controls ( P =NS). In addition, the antibody level against oxidized LDL differed significantly between nonsmokers and smokers in subjects with low HDL cholesterol (≤0.9 mmol/L) but not in subjects with high HDL cholesterol (>0.9 mmol/L). In conclusion, elevated levels of antibodies against oxidized LDL were associated with CAD. The data suggest that oxidized LDL plays a role in the pathogenesis of atherosclerosis and suggest a protective function for HDL against LDL oxidation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Myeloperoxidase and Cardiovascular Disease
Nicholls, S. J., & Hazen, S. L. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000163262.83456.6d · Cited by 795
Oxidized LDL and HDL: antagonists in atherothrombosis
Mertens, A., & Holvoet, P. (2001) · The FASEB Journal · doi:10.1096/fj.01-0273rev · Cited by 414
Mechanisms of Disease: atherosclerosis in autoimmune diseases
Sherer, Y., & Shoenfeld, Y. (2006) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0092 · Cited by 357
Lipid peroxidation, antioxidants and cardiovascular disease: how should we move forward?
Halliwell, B. (2000) · Cardiovascular Research · doi:10.1016/s0008-6363(00)00097-3 · Cited by 343
Oxidized Low-Density Lipoprotein
Parthasarathy, S., Raghavamenon, A., Garelnabi, M. O., & Santanam, N. (2010) · Methods in Molecular Biology · doi:10.1007/978-1-60327-029-8_24 · Cited by 331
Metadata
- Authors
- Lehtimäki, T., Lehtinen, S., Solakivi, T., Nikkilä, M., Jaakkola, O., Jokela, H., Ylä-Herttuala, S., Luoma, J. S., Koivula, T., & Nikkari, T.
- Venue
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Published
- 1999-01
- Volume
- 19
- Issue
- 1
- Pages
- 23-27
- ISSN
- 1079-5642 (ISSN-L)
- 1524-4636
- OpenAlex
- W2028283951
- Cited by
- 202
- References
- 0
- FWCI
- 6.09
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Autoantibodies Against Oxidized Low Density Lipoprotein in Patients With Angiographically Verified Coronary Artery Disease. https://app.cochat.ai/papers/10.1161/01.atv.19.1.23
- The paper
- Lehtimäki, T., Lehtinen, S., Solakivi, T., Nikkilä, M., Jaakkola, O., Jokela, H., Ylä-Herttuala, S., Luoma, J. S., Koivula, T., & Nikkari, T. (1999). Autoantibodies Against Oxidized Low Density Lipoprotein in Patients With Angiographically Verified Coronary Artery Disease. Arteriosclerosis, Thrombosis, and Vascular Biology. https://doi.org/10.1161/01.atv.19.1.23
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.